Plug Power

Showing 4392 articles
Business

Merck Navigates Mixed Q4 2025 with Oncology Strength Offsetting Vaccine Slump, Sets Cautious 2026 Outlook

Merck & Co. reported a 5% rise in Q4 2025 revenue to $16.4 billion, powered by its blockbuster cancer drug Keytruda and animal health division. However, a steep 35% drop in Gardasil sales, attributed to weakened demand in Asia, highlighted regional vulnerabilities. The pharmaceutical giant issued initial 2026 guidance projecting modest growth while absorbing a significant one-time charge from its recent Cidara Therapeutics acquisition.

Business

Thomson Reuters Shares Tumble as AI Legal Tool Sparks Market Jitters

Shares of Thomson Reuters (TSX:TRI) faced significant pressure this week following the release of a new AI-powered legal assistant by Anthropic. The tool's ability to automate complex workflows like contract review has ignited investor concerns over potential disruption to established legal information and technology providers, contributing to a sharp sell-off.